Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Qnovia, Inc.

Qnovia, Inc. Announces the Appointment of Four New Members to its Scientific Advisory Board
From Qnovia, Inc.
Via Business Wire
Qnovia, Inc. announces positive results from first-in-human pharmacokinetic and safety study of lead asset QN-01, a prescription inhaled smoking cessation therapy
From Qnovia, Inc.
Via Business Wire
Qnovia Enters Collaboration with University of Virginia to Advance Inhaled Drug Candidates for Treating Infectious Diseases
From Qnovia, Inc.
Via Business Wire
Qnovia to Present at Gilmartin Group Private Company Showcase
From Qnovia, Inc.
Via Business Wire
Qnovia, Inc. Announces Former Director of FDA’s Center for Tobacco Products, Mitch Zeller, as Policy and Regulatory Strategy Advisor
From Qnovia, Inc.
Via Business Wire
Qnovia to Pursue UK Approval for Lead Asset QN-01 in Nicotine Replacement Therapy
From Qnovia, Inc.
Via Business Wire
Qnovia, Inc. Raises $17 Million in Series A Funding to Advance Its Inhalable Therapeutics Pipeline
From Qnovia, Inc.
Via Business Wire
Respira Technologies, Inc. Rebrands as “QNOVIA”; Adopts Qnovia, Inc. as Corporate Name
From Qnovia, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.